NM_032634.4:c.461C>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B.

Score: -20 - Benign
-20
-12 -7 -6 -1 0 5 6 9 10 12
BP4_StrongBP6_Very_StrongBS1BS2

The NM_032634.4(PIGO):​c.461C>A​(p.Ala154Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00338 in 1,613,384 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A154T) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0026 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0035 ( 14 hom. )

Consequence

PIGO
NM_032634.4 missense

Scores

4
8
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 8.07

Publications

2 publications found
Variant links:
Genes affected
PIGO (HGNC:23215): (phosphatidylinositol glycan anchor biosynthesis class O) This gene encodes a protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid which contains three mannose molecules in its core backbone. The GPI-anchor is found on many blood cells and serves to anchor proteins to the cell surface. This protein is involved in the transfer of ethanolaminephosphate (EtNP) to the third mannose in GPI. At least three alternatively spliced transcripts encoding two distinct isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
PIGO Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hyperphosphatasia with intellectual disability syndrome 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • hyperphosphatasia-intellectual disability syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012724459).
BP6
Variant 9-35095105-G-T is Benign according to our data. Variant chr9-35095105-G-T is described in ClinVar as [Likely_benign]. Clinvar id is 262099.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00263 (401/152360) while in subpopulation NFE AF = 0.00376 (256/68036). AF 95% confidence interval is 0.00338. There are 0 homozygotes in GnomAd4. There are 216 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 14 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGONM_032634.4 linkc.461C>A p.Ala154Asp missense_variant Exon 2 of 11 ENST00000378617.4 NP_116023.2 Q8TEQ8-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGOENST00000378617.4 linkc.461C>A p.Ala154Asp missense_variant Exon 2 of 11 1 NM_032634.4 ENSP00000367880.3 Q8TEQ8-1

Frequencies

GnomAD3 genomes
AF:
0.00263
AC:
401
AN:
152242
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000724
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00118
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00885
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00376
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00318
AC:
796
AN:
250386
AF XY:
0.00322
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000869
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00976
Gnomad NFE exome
AF:
0.00470
Gnomad OTH exome
AF:
0.00262
GnomAD4 exome
AF:
0.00346
AC:
5054
AN:
1461024
Hom.:
14
Cov.:
31
AF XY:
0.00333
AC XY:
2421
AN XY:
726790
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33476
American (AMR)
AF:
0.00103
AC:
46
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26004
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86136
European-Finnish (FIN)
AF:
0.0101
AC:
540
AN:
53352
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5762
European-Non Finnish (NFE)
AF:
0.00386
AC:
4292
AN:
1111568
Other (OTH)
AF:
0.00247
AC:
149
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
325
651
976
1302
1627
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
152
304
456
608
760
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00263
AC:
401
AN:
152360
Hom.:
0
Cov.:
33
AF XY:
0.00290
AC XY:
216
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000721
AC:
30
AN:
41586
American (AMR)
AF:
0.00118
AC:
18
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00885
AC:
94
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00376
AC:
256
AN:
68036
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
23
46
70
93
116
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00296
Hom.:
3
Bravo
AF:
0.00208
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00259
AC:
10
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.00360
AC:
31
ExAC
AF:
0.00352
AC:
427
EpiCase
AF:
0.00289
EpiControl
AF:
0.00344

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hyperphosphatasia with intellectual disability syndrome 2 Benign:2
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

not provided Benign:2
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PIGO: BS1, BS2 -

Jun 02, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Nov 22, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

PIGO-related disorder Benign:1
Jun 05, 2024
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.39
BayesDel_addAF
Benign
-0.068
T
BayesDel_noAF
Uncertain
0.13
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.28
.;.;T
Eigen
Pathogenic
0.74
Eigen_PC
Pathogenic
0.77
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.94
.;D;D
M_CAP
Benign
0.022
T
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.8
L;L;L
PhyloP100
8.1
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-5.0
D;D;D
REVEL
Uncertain
0.47
Sift
Uncertain
0.0020
D;D;D
Sift4G
Uncertain
0.0040
D;D;D
Polyphen
1.0
D;D;D
Vest4
0.83
MVP
0.71
MPC
0.79
ClinPred
0.043
T
GERP RS
5.9
Varity_R
0.89
gMVP
0.97
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142562923; hg19: chr9-35095102; COSMIC: COSV108837298; COSMIC: COSV108837298; API